6499.TWO - Medeon Biodesign, Inc.

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD

Medeon Biodesign, Inc.

116, HouGang Street
7th Floor
Taipei 11170
886 2 2881 6686

IndustryMedical Instruments & Supplies
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Yue-Teh JangChairman & CEON/AN/AN/A
Ms. Hui Jing HuangVP of Fin. & Admin.N/AN/AN/A
Dr. Yi-Ju ChenVP of Corp. Devel.N/AN/AN/A
Dr. Shuling ChengChief Strategy OfficerN/AN/AN/A
Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.


Medeon Biodesign, Inc. develops and markets medical devices in Taiwan and the United States. The company offers its products for minimally invasive surgeries in the areas of cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, nephrology, obstetrics and gynecology, urology, and plastic surgery. Medeon Biodesign, Inc. was founded in 2012 and is headquartered in Taipei, Taiwan.

Corporate Governance

Medeon Biodesign, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.